Stuart H. Gold

Stuart H. Gold brings a wealth of experience in pediatric hematology-oncology to his role as a Distinguished Professor and Chief of the Division at the University of North Carolina at Chapel Hill. With a specialized focus on acute leukemia, brain tumors, and the late effects of cancer therapy, Dr. Gold is dedicated to advancing the field through both clinical practice and research. He leads a comprehensive brain tumor clinic, providing expert care and guidance to patients and families navigating these challenging diagnoses. In addition to his work in Chapel Hill, Dr. Gold extends his expertise to the broader community by running monthly clinics in Wilmington and Raleigh. His commitment to improving cancer care is further demonstrated through his active involvement in multiple cancer committees, including the Children's Cancer Group and the Chapel Hill Ronald McDonald House. These roles allow him to contribute to the development of innovative treatment protocols and support systems for children with cancer. Dr. Gold's research interests are diverse and impactful, encompassing integrative medicine, long-term survivorship issues, and improving medical outcomes for children with cancer. He is particularly focused on addressing barriers to care and enhancing palliative care services, ensuring that patients receive comprehensive support throughout their treatment journey. His work in these areas is driven by a deep commitment to improving the quality of life for pediatric cancer patients and their families. Through his leadership and research, Dr. Gold is at the forefront of efforts to integrate holistic approaches into cancer care, recognizing the importance of treating the whole patient, not just the disease. His dedication to long-term survivorship issues highlights his understanding of the ongoing challenges faced by cancer survivors and his commitment to developing strategies that promote their well-being. Dr. Gold's contributions to the field of pediatric hematology-oncology are widely recognized, and his work continues to influence the way cancer care is delivered. His passion for improving cancer outcomes and his dedication to his patients make him a respected and influential figure in the medical community.